病例报告:一名患者晚期不良反应,正在接受酸和拉莫特里金联合治疗
Hui Sang1, Liqiao Zhao1, Yanhua Zhang1
1Department of Neurology, Taiyuan City Central Hospital, The Ninth Clinical Medical College of Shanxi Medical University, Taiyuan, 030001, China.
Acta epileptologica
|April 30, 2025
概括
华酸和拉莫特里金组合治疗的晚期不良反应在中国很少见. 监测血液中药物水平对于管理患者的这些延迟副作用至关重要.
科学领域:
- 神经科学是一个神经科学.
- 临床药理学 临床药理学
背景情况:
- 在中国人群中,对氨酸和拉莫特里金联合治疗的晚期不良反应很少报告.
- 抗发作药物组合可以导致复杂的不良事件概况.
研究的目的:
- 报告一种晚期出现的益酸和拉莫特里金联合治疗不良反应的病例.
- 强调长期服用抗发作药物的患者血中药物度监测的重要性.
主要方法:
- 一个54岁的女性患者经历了不良反应的病例报告.
- 症状包括头,,阴影和震,在调节后五个月出现.
- 在不停止服用药物的情况下,进行了血液药物度监测和轻微的剂量调整.
主要成果:
- 在血液中药物水平监测和剂量轻微调整后,患者的症状成功地消失了.
- 这表明,通过仔细的治疗药物监测,可以有效地管理晚期不良反应.
结论:
- 临床医生应保持警,以防 valproate 和 lamotrigine 相关的潜在晚期不良反应.
- 血中药物度的积极监测对于服用这些抗发作药物的患者的安全和有效管理至关重要.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
180
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
180
Antiepileptic Drugs: Potassium Channel Activators
119
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
119
Antiepileptic Drugs: GABAergic Pathway Potentiators
256
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
256
Antiepileptic Drugs: Glutamate Antagonists
242
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
242
Antiepileptic Drugs: Sodium Channel Blockers
235
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
235
Arteries of the Lower Limbs
162
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
162


